• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Transfemoral aortic valve implantation with the repositionable Lotus valve for treatment of patients with symptomatic severe aortic stenosis: results from a single-centre experience.
CONCLUSIONS: In patients with severe aortic stenosis, transfemoral TAVI with the repositionable Lotus valve was associated with a high rate of device success, no moderate or severe residual aortic regurgitation, low rates of major vascular complications and mortality within 30 days. PMID: 27542789 [PubMed - in process]
Source: EuroIntervention - August 22, 2016 Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research

Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial.
CONCLUSIONS: TF-TAVI using the SAPIEN 3 THV in patients at intermediate risk for surgery is associated with a very low risk of death and complications, including new pacemakers and paravalvular leaks. Although compelling, these initial results are being confirmed in larger global studies before expanding the indications for TAVI in severe aortic stenosis. PMID: 27290682 [PubMed - in process]
Source: EuroIntervention - June 14, 2016 Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research

New Braile Inovare transcatheter aortic prosthesis: clinical results and follow-up.
CONCLUSIONS: Transcatheter aortic valve replacement using the Braile Inovare prosthesis is able to provide encouraging results with significant functional and structural cardiac improvement. It is mandatory to continue follow-up to measure the benefits of this device as well as to improve selection criteria of patients. PMID: 26499221 [PubMed - as supplied by publisher]
Source: EuroIntervention - October 27, 2015 Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research

Thirty-day VARC-2 and performance data of a new self-expanding transcatheter aortic heart valve.
CONCLUSIONS: In this first-in-human study, the feasibility of implantation of the BIOVALVE system and its re-sheathing functionality was demonstrated, and short-term safety data were encouraging. Larger studies are required to confirm the performance of the device. PMID: 25983028 [PubMed - as supplied by publisher]
Source: EuroIntervention - May 21, 2015 Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research

Preliminary outcomes after transcatheter aortic valve implantation in patients with systemic sclerosis.
CONCLUSIONS: The present case series suggests that the TAVI procedure is feasible in patients with SSc and severe AS. PMID: 25912392 [PubMed - in process]
Source: EuroIntervention - May 1, 2015 Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research

Anaesthetic management of transcatheter aortic valve implantation: results from the Italian CoreValve registry.
CONCLUSIONS: Our study indicates that, in experienced centres which have gone beyond their initial learning curve with TAVI, the use of local anaesthesia in a selected patient population can be associated with good clinical outcomes. Nevertheless, as severe procedural complications are possible, an anaesthesiologist should always be present as part of the team. PMID: 25772903 [PubMed - as supplied by publisher]
Source: EuroIntervention - March 20, 2015 Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research

Pages: 1  2  3  4